AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B ...Middle East

PR Newswire - News
AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B

SAN FRANCISCO, Dec. 26, 2024 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies to achieve a functional cure for chronic...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B )

    Also on site :